• Humacyte director Michael T. Constantino bought 11,000 shares of common stock in open-market purchases.
• The weighted average purchase price was USD 0.89 per share.
• His direct holding rose to 43,950 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humacyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817285-26-000002), on May 20, 2026, and is solely responsible for the information contained therein.